<DOC>
	<DOCNO>NCT00272935</DOCNO>
	<brief_summary>This randomize , double-blind study compare efficacy safety daily dose Cenestin 0.3 mg tablet placebo reduce frequency severity moderate severe hot flash postmenopausal woman .</brief_summary>
	<brief_title>A Clinical Trial Demonstrate Efficacy Safety Cenestin 0.3 mg Treatment Hot Flashes</brief_title>
	<detailed_description>The overall study duration approximately 16 week . After screening/baseline period 4 week patient randomize receive either placebo tablet Cenestin 0.3mg tablet</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens , conjugate synthetic A</mesh_term>
	<criteria>Naturally surgically postmenopausal At least 12 month since last menses 6 week past surgery Minimum 7 daily 50 weekly moderate severe hot flash Any contraindication natural synthetic estrogen</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>menopause</keyword>
	<keyword>vasomotor symptom</keyword>
</DOC>